Jun Zhou

8.8k total citations · 1 hit paper
190 papers, 6.8k citations indexed

About

Jun Zhou is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Jun Zhou has authored 190 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Molecular Biology, 75 papers in Cell Biology and 46 papers in Oncology. Recurrent topics in Jun Zhou's work include Microtubule and mitosis dynamics (62 papers), Ubiquitin and proteasome pathways (41 papers) and Histone Deacetylase Inhibitors Research (21 papers). Jun Zhou is often cited by papers focused on Microtubule and mitosis dynamics (62 papers), Ubiquitin and proteasome pathways (41 papers) and Histone Deacetylase Inhibitors Research (21 papers). Jun Zhou collaborates with scholars based in China, United States and India. Jun Zhou's co-authors include Dengwen Li, Paraskevi Giannakakou, Harish C. Joshi, Ritu Aneja, Min Liu, Min Liu, Songbo Xie, Jie Ran, Yunfan Yang and Jinmin Gao and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jun Zhou

184 papers receiving 6.8k citations

Hit Papers

Dynamic O-GlcNAcylation coordinates ferritinophagy and mi... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Zhou China 46 4.8k 1.9k 1.7k 726 539 190 6.8k
Marco Falasca Australia 51 5.4k 1.1× 1.6k 0.8× 2.1k 1.2× 1.1k 1.6× 862 1.6× 183 8.7k
Axel H. Schönthal United States 54 4.6k 1.0× 1.7k 0.9× 1.6k 0.9× 937 1.3× 701 1.3× 170 8.1k
Xingming Deng United States 52 5.5k 1.2× 873 0.5× 1.8k 1.1× 1.0k 1.4× 641 1.2× 103 7.4k
Philipp Kaldis United States 50 6.0k 1.3× 2.3k 1.2× 2.8k 1.6× 883 1.2× 598 1.1× 134 8.7k
Chanchal Kumar Germany 26 8.4k 1.8× 1.2k 0.6× 1.4k 0.8× 539 0.7× 506 0.9× 35 10.8k
Zhixiang Wang Canada 40 3.6k 0.8× 932 0.5× 2.0k 1.2× 681 0.9× 530 1.0× 159 6.4k
Klaus P. Hoeflich United States 36 4.8k 1.0× 570 0.3× 2.0k 1.2× 776 1.1× 572 1.1× 62 6.8k
Yong Tae Kwon South Korea 46 5.8k 1.2× 1.5k 0.8× 1.8k 1.0× 684 0.9× 541 1.0× 136 7.9k
George Panayotou Greece 48 7.9k 1.7× 2.1k 1.1× 1.5k 0.9× 789 1.1× 1.6k 3.0× 155 11.1k
Mikihiko Naito Japan 54 6.6k 1.4× 648 0.3× 3.5k 2.0× 609 0.8× 604 1.1× 224 9.7k

Countries citing papers authored by Jun Zhou

Since Specialization
Citations

This map shows the geographic impact of Jun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Zhou more than expected).

Fields of papers citing papers by Jun Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Zhou. The network helps show where Jun Zhou may publish in the future.

Co-authorship network of co-authors of Jun Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Zhou. A scholar is included among the top collaborators of Jun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Zhou. Jun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jun, et al.. (2026). Improved in vivo gene knockout with high specificity using multiplexed Cas12a sgRNAs. Nature Communications. 17(1). 877–877.
2.
Wu, Sijin, Honglin Zhou, Qingchao Li, et al.. (2025). Targeted Degradation of HCV Polymerase by GalNAc-Conjugated ApTACs for Pan-Genotypic Antiviral Therapy with High Resistance Barriers. Journal of Medicinal Chemistry. 68(2). 1473–1482. 3 indexed citations
3.
Li, Qingchao, et al.. (2025). FUT8-mediated core fucosylation stabilizes TMEM67 to promote ciliogenesis. The Journal of Cell Biology. 224(10). 1 indexed citations
4.
Zhang, Renshuai, et al.. (2025). Crosstalk between anti-angiogenic and pro-angiogenic pathways in disease: Mechanisms and therapeutic strategies. Pharmacology & Therapeutics. 276. 108934–108934.
5.
Song, Jian H., Ping Zhou, Ruizhe Qian, et al.. (2025). Targeting both wild-type EGFR and its drug-resistant mutants with erlotinib-aptamer conjugates. European Journal of Medicinal Chemistry. 296. 117871–117871.
6.
Tian, Xiaoyu, Kaiyue Zhang, Xifeng Dong, et al.. (2024). Primary cilia restrict autoinflammation by mediating PD-L1 expression. Science Bulletin. 69(16). 2505–2508. 2 indexed citations
7.
Tian, Xiaoyu, Zhenzhou Huang, Jiaying Wang, et al.. (2024). XIAP-mediated degradation of IFT88 disrupts HSC cilia to stimulate HSC activation and liver fibrosis. EMBO Reports. 25(3). 1055–1074. 13 indexed citations
8.
Chen, Yanhua, Jun Zhou, Zhaoying Wang, et al.. (2024). Plasma metabolomics combined with mass spectrometry imaging reveals crosstalk between tumor and plasma in gastric cancer genesis and metastasis. Chinese Chemical Letters. 36(1). 110351–110351. 1 indexed citations
9.
Yang, Song, Hanyu Liu, Hua Ni, et al.. (2023). O-GlcNAcylation regulates phagocytosis by promoting Ezrin localization at the cell cortex. Journal of genetics and genomics. 50(7). 486–496. 8 indexed citations
10.
Fan, Yu, Song Yang, Hua Ni, et al.. (2023). O‐GlcNAcylation Regulates Centrosome Behavior and Cell Polarity to Reduce Pulmonary Fibrosis and Maintain the Epithelial Phenotype. Advanced Science. 10(36). e2303545–e2303545. 10 indexed citations
11.
Li, Te, Yiyan Wang, Dengwen Li, et al.. (2021). Potential role for the tumor suppressor CYLD in brain and notochord development. Thoracic Cancer. 12(12). 1900–1908. 2 indexed citations
12.
Zhang, Ming, et al.. (2021). Therapeutic effects of pentoxifylline on invasive pulmonary aspergillosis in immunosuppressed mice. BMC Pulmonary Medicine. 21(1). 31–31. 13 indexed citations
13.
Zhang, Jie, et al.. (2020). Maternal exposure to Di-(2-ethylhexyl) phthalate (DEHP) activates the PI3K/Akt/mTOR signaling pathway in F1 and F2 generation adult mouse testis. Experimental Cell Research. 394(2). 112151–112151. 26 indexed citations
14.
Xie, Songbo, Juan Qin, Shiyu Liu, et al.. (2016). Cep70 overexpression stimulates pancreatic cancer by inducing centrosome abnormality and microtubule disorganization. Scientific Reports. 6(1). 21263–21263. 17 indexed citations
15.
Zhou, Jun, et al.. (2013). The role of cotyledons in the establishment of Suaeda physophora seedlings. Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology. 148(4). 584–590. 19 indexed citations
16.
Zhang, Chao, Xiaodong Sun, Yuan Ren, et al.. (2012). Validation of Polo-like kinase 1 as a therapeutic target in pancreatic cancer cells. Cancer Biology & Therapy. 13(12). 1214–1220. 9 indexed citations
17.
Pannu, Vaishali, Angela Ogden, Robert Clewley, et al.. (2012). Induction of robust de novo centrosome amplification, high-grade spindle multipolarity and metaphase catastrophe: a novel chemotherapeutic approach. Cell Death and Disease. 3(7). e346–e346. 33 indexed citations
18.
Zhou, Jun. (2009). Multi-Drug Resistance in Cancer. Methods in molecular biology. 100 indexed citations
19.
Gao, Jinmin, Lihong Huo, Xiaoou Sun, et al.. (2008). The Tumor Suppressor CYLD Regulates Microtubule Dynamics and Plays a Role in Cell Migration. Journal of Biological Chemistry. 283(14). 8802–8809. 111 indexed citations
20.
Marcus, Adam I., Jun Zhou, Aurora O’Brate, et al.. (2005). The Synergistic Combination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin Deacetylase. Cancer Research. 65(9). 3883–3893. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026